Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
HSC835
BIOLOGICAL
2 trials
Sponsors
Novartis Pharmaceuticals
Conditions
Acute Lymphocytic Leukemia
Acute Myelocytic Leukemia
Burkitt's Lymphoma
Chronic Lymphocytic Leukemia
Chronic Myelogenous Leukemia
Follicular Lymphomas
High Grade Lymphomas
Large-cell Lymphoma
+9 more
Phase 1
Safety and Tolerability of HSC835 in Patients With Hematological Malignancies
Completed
NCT01474681
Novartis Pharmaceuticals
Acute Lymphocytic Leukemia, Acute Myelocytic Leukemia, Burkitt's Lymphoma +10
Start: 2012-01-09
End: 2016-10-03
Updated: 2020-12-30
Phase 2
Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood Transplant
Completed
NCT01930162
Novartis Pharmaceuticals
Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Multiple Myeloma +4
Start: 2014-10-07
End: 2016-08-29
Updated: 2021-01-05